Vis børsmeldingen
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED
STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR
DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER
OF ANY OF THE SECURITIES DESCRIBED HEREIN
Reference is made to the stock exchange announcements by Aqua Bio Technology ASA
(“ABTEC” or the “Company”) on 26 March 2025 regarding the terms of a subsequent
offering of up to 20,000,000 new shares (the “Offer Shares”) in the Company (the
“Subsequent Offering”) and on 27 March 2025 regarding the start of the
subscription period in the Subsequent Offering. Each Offer Share is offered at a
subscription price of NOK 0.50.
The subscription period for the Subsequent Offering (the “Subscription Period”)
will expire today, 3 April 2025 at 16:30 hours (CEST). Subscription rights that
are not used to subscribe for Offer Shares before the expiry of the Subscription
Period will have no value and will lapse without compensation to the holder.
Correctly completed subscription forms must be received by Norne Securities AS
(the “Settlement Agent”) prior to the expiry of the Subscription Period, or in
the case of online subscriptions, be registered prior to the expiry of the
Subscription Period.
For further information on the Subsequent Offering, please refer to the
Company’s stock exchange notice dated 26 March 2025, and the invitation letter
attached thereto.
Norne Securities AS is acting as Settlement Agent for the Subsequent Offering.
Advokatfirmaet CLP DA is acting as legal counsel to the Company in the
Subsequent Offering.
For further information, please contact Fredrik Henriksen, CEO, Phone +47 900 20
078.
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
IMPORTANT INFORMATION
This announcement is not an offer to sell or a solicitation of offers to
purchase or subscribe for shares. Copies of this announcement may not be sent to
jurisdictions, or distributed in or sent from jurisdictions, in which this is
barred or prohibited by law. The information contained herein shall not
constitute an offer to sell or the solicitation of an offer to buy, in any
jurisdiction in which such offer or solicitation would be unlawful absent
registration, or an exemption from registration or qualification under the
securities laws of any jurisdiction.
This document is not for publication or distribution in, directly or indirectly,
Australia, Canada, Japan, Hong Kong or the United States or any other
jurisdiction in which such release, publication or distribution would be
unlawful, and it does not constitute an offer or invitation to subscribe for or
purchase any securities in such countries or in any other jurisdiction. In
particular, the document and the information contained herein should not be
distributed or otherwise transmitted into the United States or to publications
with a general circulation in the United States of America.
This announcement is not an offer for sale of securities in the United States.
Securities may not be offered or sold in the United States absent registration
with the United States Securities and Exchange Commission or an exemption from
registration under the U.S. Securities Act of 1933, as amended (the “Securities
Act”). The Company does not intend to register any part of the offering in the
United States or to conduct a public offering in the United States of the shares
to which this document relates. This announcement is for information purposes
only and is not to be relied upon in substitution for the exercise of
independent judgment. It is not intended as investment advice and under no
circumstances is it to be used or considered as an offer to sell, or a
solicitation of an offer to buy any securities or a recommendation to buy or
sell any securities of the Company.
This announcement and any materials distributed in connection with this
announcement may contain certain forward-looking statements. By their nature,
forward-looking statements involve risk and uncertainty because they reflect
current expectations and assumptions as to future events and circumstances that
may not prove accurate. A number of material factors could cause actual results
and developments to differ materially from those expressed or implied by these
forward-looking statements.
The Company expressly disclaims any obligation or undertaking to update, review
or revise any statement contained in this announcement whether as a result of
new information, future developments or otherwise.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
- Fredrik Henriksen, CEO, Aqua Bio Technology ASA, +47 90 02 00 78,
fredrik.henriksen@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood.
The group has distribution towards B2C, B2B, B2B2, and freight, customs, and
logistics services. The group also develops sustainable biotechnology for use in
skincare products. Aqua Bio Technology is listed on the Euronext Expand market
of the Oslo Stock Exchange.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18482971/5910/Download%20announce
ment%20as%20PDF.pdf
Kilde
